Protalix BioTherapeutics, Inc. (PLX) Net Income (Loss) Attributable to Parent USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Protalix BioTherapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2024.
  • Protalix BioTherapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending March 31, 2024 was -$4.6 M, a 46.8% decline year-over-year.
  • Protalix BioTherapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending March 31, 2024 was $6.85 M.
  • Protalix BioTherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $8.31 M.
  • Protalix BioTherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$14.9 M, a 45.9% increase from 2021.
  • Protalix BioTherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$27.6 M, a 323% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $6.85 M -$4.6 M -$1.46 M -46.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $8.31 M -$6.04 M -$2.3 M -61.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $10.6 M -$1.85 M +$1.72 M +48.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 $8.9 M $19.3 M +$24.7 M Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 -$15.8 M -$3.13 M -$845 K -37% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$14.9 M -$3.74 M +$2.93 M +43.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 -$17.9 M -$3.57 M +$632 K +15.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$18.5 M -$5.33 M +$5.91 M +52.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$24.4 M -$2.29 M +$3.19 M +58.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$27.6 M -$6.67 M -$7.06 M -1779% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 -$20.5 M -$4.2 M +$238 K +5.36% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$20.8 M -$11.2 M -$7.09 M -171% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$13.7 M -$5.48 M -$7.14 M -428% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$6.52 M $397 K +$106 K +36.4% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 -$6.63 M -$4.44 M -$877 K -24.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$5.75 M -$4.15 M +$3.59 M +46.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$9.35 M $1.67 M +$8.93 M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$18.3 M $291 K +$5.73 M Oct 1, 2019 Dec 31, 2019 10-K 2020-03-12
Q3 2019 -$24 M -$3.56 M +$1.76 M +33.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-29
Q2 2019 -$25.8 M -$7.74 M +$719 K +8.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$26.5 M -$7.26 M -$25 K -0.35% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-01
Q4 2018 -$26.5 M -$5.43 M +$7.87 M +59.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$34.3 M -$5.32 M +$6.12 M +53.5% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$40.4 M -$8.46 M -$8.91 M -1980% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$31.5 M -$7.24 M +$51.9 M +87.8% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 -$83.4 M -$13.3 M -$10.7 M -407% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 -$72.8 M -$11.4 M -$4.15 M -56.9% Jul 1, 2017 Sep 30, 2017 10-Q/A 2019-03-18
Q2 2017 -$68.6 M $450 K +$11.3 M Apr 1, 2017 Jun 30, 2017 10-Q/A 2019-03-18
Q1 2017 -$79.9 M -$59.1 M -$50.6 M -588% Jan 1, 2017 Mar 31, 2017 10-Q/A 2019-03-18
Q4 2016 -$29.4 M -$2.62 M -$75.5 M -104% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 $46.2 M -$7.29 M -$3.47 M -90.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $49.6 M -$10.9 M -$5.78 M -114% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $55.4 M -$8.6 M -$2.63 M -44% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $58 M $72.9 M +$81.4 M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-06
Q3 2015 -$23.3 M -$3.82 M +$4.19 M +52.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$27.5 M -$5.07 M +$1.05 M +17.1% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$28.6 M -$5.97 M +$1.37 M +18.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$29.9 M -$8.47 M +$2.42 M +22.2% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$32.4 M -$8.01 M -$2.26 M -39.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$30.1 M -$6.12 M +$718 K +10.5% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$30.8 M -$7.35 M -$3.02 M -70% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$27.8 M -$10.9 M -$1.01 M -10.2% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-08
Q3 2013 -$26.8 M -$5.75 M -$268 K -4.89% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$26.5 M -$6.84 M -$16.5 M -171% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$10 M -$4.32 M +$1.58 M +26.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$11.6 M -$9.88 M -$964 K -10.8% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-12
Q3 2012 -$10.7 M -$5.48 M +$3.4 M +38.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 -$14.1 M $9.64 M +$23.3 M Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$37.4 M -$5.9 M -$852 K -16.9% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$36.5 M -$8.91 M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-13
Q3 2011 -$8.88 M -$6.4 M -259% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-07
Q2 2011 -$13.7 M -$3.65 M -36.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-03
Q1 2011 -$5.05 M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q3 2010 -$2.47 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 -$10 M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.